Bridgebio Pharma Inc (BBIO)

07:40 AM

BridgeBio to Participate in December Investor Conferences - The Manila Times

07:40 AM

07:30 AM

BridgeBio (Nasdaq: BBIO) to present at Piper Sandler and EvercoreISI conferences - Stock Titan

07:30 AM

03:44 AM

BridgeBio Pharma Insider Sold Shares Worth $1,722,224, According to a Recent SEC Filing - MarketScreener

03:44 AM

Nov 24, 2025

BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares By Investing.com - Investing.com Nigeria

Nov 24, 2025

Nov 24, 2025

BridgeBio Pharma CEO Kumar Neil sells $1.7m in shares - Investing.com

Nov 24, 2025

Nov 24, 2025

Biotech Stock Could Turn 4-Year Peak Into Records - Finviz

Nov 24, 2025

Nov 24, 2025

BridgeBio Pharma stock hits 52-week high at 69.69 USD By Investing.com - Investing.com Australia

Nov 24, 2025

Nov 24, 2025

BridgeBio Pharma stock hits 52-week high at 69.69 USD - Investing.com India

Nov 24, 2025

Nov 23, 2025

BridgeBio Pharma: Set For New Commercial Launches After Trial Successes - Seeking Alpha

Nov 23, 2025

Nov 22, 2025

BridgeBio Pharma (BBIO) Price Target Increased by 16.55% to 82.90 - MSN

Nov 22, 2025

Nov 21, 2025

BridgeBio Pharma Independent Director Wen-Chaun Lo Sells 62% Of Holding - simplywall.st

Nov 21, 2025

Nov 21, 2025

Will BridgeBio Pharma Inc. stock split attract more investors2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com

Nov 21, 2025

Nov 20, 2025

Will BridgeBio Pharma Inc. (2CL) stock outperform value peersWall Street Watch & Low Drawdown Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Will BridgeBio Pharma Inc. stock gain from lower inflationJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com

Nov 20, 2025

Nov 20, 2025

Why BridgeBio Pharma Inc. (2CL) stock stays resilientMarket Volume Report & Weekly High Momentum Picks - newser.com

Nov 20, 2025

Nov 20, 2025

Can BridgeBio Pharma Inc. (2CL) stock ride next bull market cycle2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

How BridgeBio Pharma Inc. stock performs in stagflationShare Buyback & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Bridgebio Pharma Insider Sold Shares Worth $6,319,662, According to a Recent SEC Filing - MarketScreener

Nov 19, 2025

Nov 19, 2025

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 19, 2025

Nov 19, 2025

BridgeBio Pharma (Nasdaq: BBIO) approves 34,199 inducement RSUs for 12 new employees - Stock Titan

Nov 19, 2025

Nov 19, 2025

Analyzing BridgeBio Pharma Inc. with risk reward ratio chartsMarket Rally & Verified Chart Pattern Signals - newser.com

Nov 19, 2025

Nov 19, 2025

How dovish Fed policy supports BridgeBio Pharma Inc. (2CL) stockWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

BridgeBio Pharma Insider Sold Shares Worth $1,125,404, According to a Recent SEC Filing - MarketScreener

Nov 19, 2025

Nov 19, 2025

BridgeBio Pharma (BBIO) president Trimarchi sells $1.12 million in stock By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 18, 2025

BridgeBio Pharma (BBIO) president Trimarchi sells $1.12 million in stock - Investing.com India

Nov 18, 2025

Nov 17, 2025

What moving averages say about BridgeBio Pharma Inc.Weekly Trade Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

BridgeBio Pharma (BIT:1BBIO) Price Target Increased by 19.13% to 72.40 - Nasdaq

Nov 17, 2025